and that above this value there is a good correlation between injury and quantities of antibody administered.9 10 There is thus a rational basis for early and effective reduction in circulating antibody even if complete arrest of antibody synthesis cannot be achieved. Others have argued that continued generation of antibody in patients with Goodpasture's syndrome may be related to the release of glomerular basement antigens from the diseased kidney and have therefore advocated bilateral nephrectomy in patients with uncontrolled pulmonary haemorrhage."1 So far the results of this approach have been mixed: in some cases lung haemorrhage has stopped,'2 18 but in others this procedure has been followed by further pulmonary bleeding.'4 Intensive plasmapheresis combined with immunosuppressive drugs would certainly seem to be worth considering in any patient with life-threatening lung haemorrhage before submitting him or her to bilateral nephrectomy.
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SHORT REPORTS Epigastric Pain in Duodenal Ulcer
Some investigators have thought that pain in duodenal ulceration is due to the direct effect of acid on the ulcer.' Others have claimed that mobility of the gastroduodenal region is disturbed during pain., Nevertheless, when muscular activity of the gastroduodenal region was abolished without affecting the acidity, ulcer pain was not relieved.3 Earlam has suggested that the pain arises from hypersensitivity of the lower oesophageal mucosa to acid." To test this hypothesis we have studied the gastro-oesophageal junction in 44 patients with proved duodenal ulceration.
Patients, Methods, and Results
Thirty-seven of 44 patients with radiologically and endoscopically proved duodenal ulcer (group A) had central epigastric pain, below the xiphisternum in the midline between the costal margins, and seven (group B) had nonepigastric pain. In all patients the function of the gastro-oesophageal junction was assessed by oesophageal manometry; acid infusion test; and radiography. Informed consent was obtained from all patients.
Patients in group A had a mean pressure of 13-1 mm ± 5-6 S.D., while those in group B had a mean of 13-0 mm ± 4-04 S.D. (see fig.) . During the acid infusion 12 experienced only retrosternal pain-nine in group A and three in group B. Another 12 complained of their usual epigastric pain and three of these experienced retrosternal pain. Any pain was abolished by 2-4% bicarbonate infusion of the oesophagus, but when 01 N HCI was reinfused the pain always returned. In ur of the 12 patients in whom acid infusion caused epigastric pain 200 ml of 2 4% bicarbonate solution was instilled into the stomach. When acid was reinfused into the oesophagus the Spipstric pam did not recur despite the infusion continuing for 30 minutes.
The remamiing 20 patients (16 in group A and four in group B) did not experience any pain during the acid infusion.
Nine patients in group A and two in group B had a relevant radiological abnormality of the gastro-oesophageal junction. Among the 28 who had positive nasal challenge tests with mite extract 21 were improved when on beclomethasone dipropionate and only seven when on placebo (P <0.04). Among the 17 patients with negative challenge tests to mite extract eight were assessed as better when on treatment, eight better on placebo, and one unchanged.
Discussion
The results in the pollen-sensitive patients were that nine out of the 13 allocated to treatment with beclomethasone dipropionate were improved while only two of the 11 patients allocated to the placebo aerosol were improved. This difference is statistically indicative of a beneficial effect of the treatment in hay fever (P <0.05 Withdrawal of systemic corticosteroid treatment is a provocative factor in the development of generalized pustular psoriasis (G.P.P.) from chronic psoriasis.' The advent of a topical preparation more potent than previously available poses the question of whether a similar "rebound" effect might occur on reduction or withdrawal of its use. This is a report of two cases in which, after topical clobetasol propionate was withdrawn, G.P.P. developed for the first time in the patients' history.
Case Histories
A woman of 54 with chronic psoriasis for 40 years-treated recently with a proprietary tar-containing preparation-was started on clobetasol propionate ointment (Dermovate, Glaxo) by her doctor in August 1974. The schedule was designed to tail off the treatment as soon as a satisfactory response was obtained. Initially the response was excellent but plaques which had had no treatment for a week or two began to reappear, seemed more inflamed than usual, and had pustulation at the edges. At the outpatient clinic in December 1974 she had had no topical treatment for six weeks and her psoriasis showed widespread annular lesions with extensive pustulation (Lapiere form of G.P.P.). She was admitted immediately; response to routine non-steroid treatment was poor though active pustulation stopped after two weeks. Extensive investigation showed no appreciable abnormality apart from a mild iron-deficiency anaemia, attributed to abstinence from meat. The deficiency responded to oral iron. In January 1975 she was started on methotrexate treatment to induce a remission and she has improved steadily ever since.
The second patient was a 45-year-old man with a seven-year history of chronic psoriasis. Since coming under our department's care he had had two periods of inpatient treatment with tar preparations supplemented by betamethasone valerate ointment. His psoriasis had tended to relapse within a few weeks of discharge, but had always shown itself as chronic scaly plaques. In June 1974 he was admitted during a phase of worsening psoriasis which was treated with tar and salicylic acid ointment supplemented with the new preparation clobetasol propionate ointment; there was some improvement and the steroid preparation was diluted. Because his psoriasis was recalcitrant full-scale investigation was arranged, including liver biopsy, to prepare him for methotrexate treatment. This was started, but produced a dramatic fall in his platelet count so it was decided that he was not suitable for long-term methotrexate. When discharged in October 1974 he was treating his trunk and limbs with one-tenth strength clobetasol propionate cream. Nevertheless, he did not use the ointment on his thighs and, within two weeks of discharge, stopped using it altogether. When seen for followup in November he had widespread psoriasis with numerous flaccid pustules over whole plaques on his trunk and legs (incipient Zumbusch type of G.P.P.). He was admitted immediately and improved somewhat with the reintroduction of clobetasol propionate ointment, but after a month pustulation was still present on the thighs (the first site from which clobetasol had been withdrawn completely) and it was decided to treat him with azathioprine. He improved slowly over three weeks and all pustulation stopped.
Conclusion
While "rebound" after topical steroid treatment of psoriasis is recognized, hitherto we have not had a topical preparation potent
